Where Global Innovation
and Capital Meet
Sectors ConsumerUniversityEnergyFinancialHealthcareIndustrialITMediaServicesTelecomsTransportThe Art of CVCStartups

Page 61

Daily Deal Round Up: November 25, 2021

Bent Pixels co-led new media company Hepmil Media's first funding round while dating app developer East Meets East completed a DeNA-led series A.

Nov 25, 2021

Deals: November 25, 2021

Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

Nov 25, 2021

Vision Medicals wins $47m

The medical technology developer received series D funding from investors including existing backer Tencent, pushing its total funding past $120m.

Nov 25, 2021

Stilla collects $35m

Illumina helped the digital PCR technology developer secure fresh convertible bond and loan financing that will be used for international expansion and the further development of its platform.

Nov 25, 2021

Luma Health hauls in $130m

The Texas Medical Center and Cisco-backed healthcare administration platform developer raised series C financing that took its overall funding to $160m.

Nov 24, 2021

Cornerstone Robotics operates series B round

The surgical robotics developer received $78.3m in funding from investors including New World Development, Lilly Asia Ventures and Meituan's DragonBall Capital fund.

Nov 24, 2021

Ieso institutes $53m series B round

Sony Innovation Fund took part in a series B round for the digital medicine technology developer as it seeks to expand in the UK and US.

Nov 24, 2021

Neurophth sees its way to over $60m

Sunshine Insurance took part in the eye-focused gene therapy developer's series C round, which pushed its overall funding past $140m.

Nov 24, 2021

Daily Deal Round Up: November 23, 2021

Coinbase Ventures contributed to a $55m round for music-focused NFT platform developer Royal while neural search technology developer Jina AI raised $30m in an SAP-backed round.

Nov 23, 2021

Vigil Neuroscience files for IPO

The neurodegenerative disease therapy developer has set a $100m placeholder target for an offering following $140m in funding from investors including Amgen and Pivotal BioVentures.

Nov 23, 2021
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here